Prostate Cancer - Results from #2080

Quantitative ADC: An Additional Tool in the Evaluation of Prostate Cancer? October 2, 2023

PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors. October 2, 2023

Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers. October 2, 2023

Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial. October 2, 2023

High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions. October 1, 2023

Direct Patlak Reconstruction of [68Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study. September 29, 2023

T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. September 29, 2023

Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study. September 29, 2023

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer. September 29, 2023

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation. September 29, 2023

Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer. September 29, 2023

The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer. September 28, 2023

The utility of [18F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate Resistant Prostate Cancer Patients (nmCRPCp): Diagnostic performance and Impact on Management. September 28, 2023

Association Between Urologist Merit-based Incentive Payment System Performance and Quality of Prostate Cancer Care. September 28, 2023

Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis. September 28, 2023

Conditional Risks of Biochemical Failure and Prostate Cancer-Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials. September 28, 2023

Precision intervention for prostate cancer: Re-evaluating who is at risk. September 28, 2023

A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance. September 28, 2023

Docetaxel radiosensitizes castration resistant prostate cancer by downregulating CAV-1. September 27, 2023

Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis. September 27, 2023

Page 105 of 1439